Stanford University - Lucile Packard Children's Hospital
Palo Alto, California, 94304, United States
NCT Number: NCT04193579
The purpose of this study is to examine whether playing recordings of a mother's voice to her infant while in the hospital nursery is an effective treatment for promoting healthy brain and language development in infants born preterm.
Looking for future studies?
Notify Me24 week–31 week
All sexes
Interventional
Not applicable
Palo Alto, California, 94304, United States
Children born preterm are at-risk for developmental language delays. Language problems in preterm children are thought to be related to neurobiological factors, including injuries to white matter structures of the brain and environmental factors, including decreased exposure to maternal speech in the hospital nursery. There is evidence to suggest that maternal speech input may be important for promoting healthy brain and language development.
Participants will be randomly assigned to one of two study groups. Each infant has a 50% chance of being assigned to the group that will listen to a recording of his/her mother's voice and a 50% chance of being assigned to the group that will not be played a voice recording. Mother's of participating infants will have her voice recorded as she reads a common children's storybook. Recordings will be played to infants each day until s/he is discharged from the hospital. To assess the long term impacts of this treatment, research participants and their families will be asked to return for follow-up visiting to perform an MRI brain scan and complete questionnaires and test that assess language development. Follow-up visit occur when infants are between 12 to 18 months of age.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Recording of a mother's voice reading a children's storybook.
Standard of Care
Other names: Standard of Care
Time frame: 18 month follow-up adjusted age for preterm birth
Parent questionnaire of receptive and expressive language skills. Will be used to assess the long-term impact of intervention on language outcomes. Standard scores are based on percentiles for age and sex and range from <1 to 99th percentile. Raw scores range from 0 to 680. Both higher standard scores and raw scores indicate better performance.
Time frame: Assessed at near-term equivalent age MRI scan (approx. 36-37 weeks postmenstrual age) or at time of hospital discharge, whichever comes first
Diffusion MRI metric that measures the average rate of water diffusion. It is used to assess white matter development and structure.
Time frame: Assessed at near-term equivalent age MRI scan (approx. 36-37 weeks postmenstrual age) or at time of hospital discharge, whichever comes first
Diffusion MRI metric that measures the directionality of water diffusion in the brain. It is used to assess white matter development and structure.
Time frame: Assessed at 12 month follow-up MRI
Diffusion MRI metric that measures the average rate of water diffusion. It is used to assess white matter development and structure
Time frame: Assessed at 12 month follow-up MRI
Diffusion MRI metric that measures the directionality of water diffusion in the brain. It is used to assess white matter development and structure.
Time frame: 12 month follow-up adjusted for preterm birth
Parent questionnaire of receptive and expressive language skills. Will be used to assess the long-term impact of intervention on language outcomes. Standard scores are based on percentiles for age and sex and range from <1 to 99th percentile. Raw scores range from 0 to 396. Both higher standard scores and raw scores indicate better performance.
Time frame: measured daily and beginning at start of treatment and until end of treatment, approximately 37-40 weeks PMA
Reflects degree of cardiorespiratory stability
Time frame: measured daily and beginning at start of treatment and until end of treatment, approximately 37-40 weeks PMA
days until 100 % of nutrition administered orally
Time frame: measured daily and beginning at start of treatment and until end of treatment, approximately 37-40 weeks PMA
measured as weight gain per day
Stanford University
Other
Listening to Mom in the Neonatal Intensive Care Unit (NICU): Neural, Clinical and Language Outcomes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02847689
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
Palo Alto, California, United States
View Trial DetailsNCT05264779
Female Urogenital Diseases and Pregnancy Complications, Obstetric Labor Complications
San Diego, California, United States
View Trial DetailsNCT07577388
Abortion, Habitual, Abortion, Spontaneous
View Trial DetailsNCT05114096
Complication of Prematurity, Female Urogenital Diseases and Pregnancy Complications
Calgary, Alberta, Canada
View Trial Details